Advancing isotope production and medical innovation

Texas has long been a global leader in both energy innovation and medical breakthroughs. Oklo is building on that legacy in the Lone Star State, working alongside Texas communities to advance technologies that support both.

Oklo is helping restore U.S. isotope independence, enabling medical breakthroughs, strengthening American manufacturing, and supporting technologies that improve everyday life.

The Groves Isotopes Test Reactor

In Lockhart, Oklo will use the Versatile Isotope Production Reactor (VIPR) concept to produce isotopes used across medicine, industry, research, and national security.

This process:

Demonstrates

reactor startup and operations while validating the VIPR reactor performance

Tests

isotope production pathways and generates essential operational data that supports future reactor licensing

Creates

isotopes that power next-generation cancer treatments, advanced manufacturing, scientific discovery, and critical national capabilities

Benefits to Texas

This project delivers tangible local benefits:

Creates high-quality jobs across engineering, operations, and technical fields

Supports workforce development and training

Contributes to regional economic growth

Positions Texas as a leader in advanced nuclear and isotope production

Project timing

Subject to certain regulatory approvals, Oklo projects the following high-level, community-facing project milestones:

Milestones Expected timing
Target to reach criticality / Expected operational July 2026

Looking ahead

Oklo’s work in Texas is part of a broader platform spanning power, fuel recycling, and isotopes, each reinforcing long-term deployment and supply reliability.

The Groves Isotope Test Reactor is a key step, demonstrating advanced reactor operations and validating isotope production ahead of commercial scale.

This work lays the foundation for future facilities and expanded domestic production later this decade, helping ensure critical technologies are built and scaled in the United States, with Texas playing a central role.

 

Learn more about Oklo's isotopes business line here